Your browser doesn't support javascript.
loading
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Morschhauser, Franck; Feugier, Pierre; Flinn, Ian W; Gasiorowski, Robin; Greil, Richard; Illés, Árpád; Johnson, Nathalie A; Larouche, Jean-François; Lugtenburg, Pieternella J; Patti, Caterina; Salles, Gilles A; Trnený, Marek; de Vos, Sven; Mir, Farheen; Samineni, Divya; Kim, Su Y; Jiang, Yanwen; Punnoose, Elizabeth; Sinha, Arijit; Clark, Emma; Spielewoy, Nathalie; Humphrey, Kathryn; Bazeos, Alexandra; Zelenetz, Andrew D.
Afiliación
  • Morschhauser F; Université de Lille, Centre Hospitalier Universitaire (CHU) Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées (ULR 7365-GRITA), Lille, France.
  • Feugier P; CHU de Nancy, Université de Lorraine, Vandoeuvre lès Nancy, France.
  • Flinn IW; Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN.
  • Gasiorowski R; Concord Hospital, University of Sydney, Sydney, NSW, Australia.
  • Greil R; Paracelcus Medical University Salzburg, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.
  • Illés Á; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Johnson NA; Jewish General Hospital, Montreal, QC, Canada.
  • Larouche JF; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec City, QC, Canada.
  • Lugtenburg PJ; HOVON Lunenburg Lymphoma Phase I-II Consortium, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Patti C; Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Salles GA; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Bénite, France.
  • Trnený M; First Department of Medicine, Charles University General Hospital, Prague, Czech Republic.
  • de Vos S; David Geffen School of Medicine, University of California (UCLA), Los Angeles, CA.
  • Mir F; Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Samineni D; Genentech, Inc., South San Francisco, CA.
  • Kim SY; AbbVie, North Chicago, IL.
  • Jiang Y; Genentech, Inc., South San Francisco, CA.
  • Punnoose E; Genentech, Inc., South San Francisco, CA.
  • Sinha A; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Clark E; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Spielewoy N; F. Hoffmann-La Roche Ltd., Basel, Switzerland; and.
  • Humphrey K; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Bazeos A; Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY.
Blood ; 137(5): 600-609, 2021 02 04.
Article en En | MEDLINE | ID: mdl-33538797
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged80 Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged80 Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Francia